By


Relmada Therapeutics Reinforces Balance Sheet with $15.2 Million from Exercise of Warrants
Read more here

By


Melior Pharmaceuticals Receives First Performance Milestone Payment from Bukwang Pharmaceutical
Read more here

By


Infrascanner™ Brain Scanner Gets $3.7M-Expands head trauma detection capabilities
Read more here

By


Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER
Read more here

By


Relmada Announces the Filing of Clinical Trial Application in Canada for D-Methadone
Read more here

By


Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies
Read more here

By


Galleon Pharmaceuticals Announces Publication of Proof-of-Concept Clinical Studies for GAL-021, Projected Use for the Emerging Perioperative Sleep Apnea Epidemic
Read more here